Glucose metabolism in heart transplant recipients treated with FK506 or cyclosporine

被引：0
|
作者：
Sahar, G
Berman, M
Ben-Gal, T
Sahar, E
Kogan, A
Michowitch, R
Saute, M
Kramer, M
Sagie, A
Shapira, Y
Aravot, D
Vidne, BA
机构：
[1] Tel Aviv Univ, Sackler Fac Med, Rabin Med Ctr, Dept Cardiothorac Surg,Heart Lung Transplant Unit, IL-49100 Petah Tiqwa, Israel
[2] Tel Aviv Univ, Sackler Fac Med, Rabin Med Ctr, Dept Cardiol, IL-49100 Petah Tiqwa, Israel
[3] Tel Aviv Univ, Sackler Fac Med, Rabin Med Ctr, Pulm Inst, IL-49100 Petah Tiqwa, Israel
来源：
TRANSPLANTATION PROCEEDINGS | 2003年 / 35卷 / 02期
关键词：
D O I：
10.1016/S0041-1345(03)00095-2
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：678 / 678
页数：1
相关论文
共 50 条
  • [1] Bone mass and mineral metabolism in liver transplant patients treated with FK506 or cyclosporine A
    A. Monegal
    M. Navasa
    N. Guañabens
    P. Peris
    F. Pons
    M. J. Martínez de Osaba
    A. Rimola
    J. Rodés
    J. Muñoz-Gómez
    [J]. Calcified Tissue International, 2001, 68 : 83 - 86
  • [2] Bone mass and mineral metabolism in liver transplant patients treated with FK506 or cyclosporine A
    Monegal, A
    Navasa, M
    Guañabens, N
    Peris, P
    Pons, F
    de Osaba, MJM
    Rimola, A
    Rodés, J
    Muñoz-Gómez, J
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2001, 68 (02) : 83 - 86
  • [3] DIABETOGENICITY OF FK506 VERSUS CYCLOSPORINE IN LIVER-TRANSPLANT RECIPIENTS
    JINDAL, RM
    POPESCU, I
    SCHWARTZ, ME
    EMRE, S
    BOCCAGNI, P
    MILLER, CM
    [J]. TRANSPLANTATION, 1994, 58 (03) : 370 - 372
  • [4] LATE EFFECTS OF CYCLOSPORINE AND FK506 ON LIPID-METABOLISM IN LIVER-TRANSPLANT RECIPIENTS
    MOR, E
    ATILLASOV, E
    KREIZMAN, I
    KOLESNIKOV, V
    MORAN, V
    SCHWARTZ, B
    SHEINER, PA
    SCHWARTZ, ME
    MILLER, CM
    BERK, P
    [J]. HEPATOLOGY, 1994, 20 (04) : A123 - A123
  • [5] Neurotoxicity in pediatric renal transplant recipients treated with FK506 (tacrolimus).
    Neu, AM
    Furth, SL
    Case, BW
    Wise, B
    Colombani, PM
    Fivush, BA
    [J]. PEDIATRIC RESEARCH, 1996, 39 (04) : 2177 - 2177
  • [6] Interaction of cyclosporine and FK506 with diuretics in transplant patients
    Arthur, JM
    Shamim, S
    [J]. KIDNEY INTERNATIONAL, 2000, 58 (01) : 325 - 330
  • [7] Hypomagnesia and arrhythmia corrected by replacing cyclosporine with FK506 in a heart transplant recipient
    Ko, WJ
    Lin, FL
    Wang, SS
    Chu, SH
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 1997, 16 (09): : 980 - 982
  • [8] LONG-TERM EFFECTS OF FK506 FOLLOWING CONVERSION FROM CYCLOSPORINE TO FK506 FOR CHRONIC REJECTION IN LIVER-TRANSPLANT RECIPIENTS
    FUNG, JJ
    JAIN, A
    HAMMAD, I
    DOYLE, H
    SELBY, R
    TZAKIS, AG
    TODO, S
    STARZL, TE
    [J]. HEPATOLOGY, 1993, 18 (04) : A74 - A74
  • [9] Steroid withdrawal in tacrolimus (FK506)-treated pediatric liver transplant recipients
    McKee, M
    Mattei, P
    Schwarz, K
    Wise, B
    Colombani, P
    [J]. JOURNAL OF PEDIATRIC SURGERY, 1997, 32 (07) : 973 - 975
  • [10] POSTOPERATIVE GLUCOSE-METABOLISM IN LIVER-TRANSPLANT RECIPIENTS - A 2-YEAR PROSPECTIVE RANDOMIZED STUDY OF CYCLOSPORINE VERSUS FK506
    KRENTZ, AJ
    DMITREWSKI, J
    MAYER, D
    MCMASTER, P
    BUCKELS, J
    DOUSSET, B
    CRAMB, R
    SMITH, JM
    NATTRASS, M
    [J]. TRANSPLANTATION, 1994, 57 (11) : 1666 - 1669
12345